FULL STATEMENT FROM AMERICAN COLLEGE OF PEDIATRICS ON TRANS

New Post Public Reply Private Reply Replies (1) Message Board
energy_wave
634
FULL STATEMENT FROM AMERICAN COLLEGE OF PEDIATRICS ON TRANS DRUGS FOR KIDS


Quote:
"As physicians, together with nurses, psychotherapists and behavioral health clinicians, other health professionals, scientists, researchers, and public health and policy professionals, we have serious concerns about the physical and mental health effects of the current protocols promoted for the care of children and adolescents in the United States who express discomfort with their biological sex.

Therefore, given the recent research and the revelations of the harmful approach advocated by WPATH and its followers in the United States, we, the undersigned, call upon the medical professional organizations of the United States, including the American Academy of Pediatrics, the Endocrine Society, the Pediatric Endocrine Society, American Medical Association, the American Psychological Association, and the American Academy of Child and Adolescent Psychiatry to follow the science and their European professional colleagues and immediately stop the promotion of social affirmation, puberty blockers, cross-sex hormones and surgeries for children and adolescents who experience distress over their biological sex.

Instead, these organizations should recommend comprehensive evaluations and therapies aimed at identifying and addressing underlying psychological co-morbidities and neurodiversity that often predispose to and accompany gender dysphoria.

We also encourage the physicians who are members of these professional organizations to contact their leadership and urge them to adhere to the evidence-based research now available.”

Source: doctorsprotectingchildren.org


https://x.com/MarioNawfal/status/1799320945410060542
big-wave_surfing_01.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

The Future of Pharmaceutical Contract Packaging: Growth Insights

Updated Category News Views 74

Overview of the Pharmaceutical Contract Packaging Market The global market for pharmaceutical contract packaging is set to experience notable growth, propelled by advances in technology and increased investment in research and development. Estimates indicate a remarkable increase of USD 9.32 billion from 2024 to 2028, equating to a compound annual growth rate (CAGR) of...

Continue Reading
Palantir's CTO Highlights US Deterrence Challenges Ahead

Updated Category News Views 209

Palantir's CTO Discusses National Security Challenges Shyam Sankar, the Chief Technology Officer of the innovative data analytics and cybersecurity company Palantir Technologies Inc. (NASDAQ: PLTR), recently expressed serious concerns regarding America's fading deterrence capacity. While appearing on the New York Times podcast, he made it clear that the nation is no...

Continue Reading
Concerns Rise for Long-Term Investors of Super Micro Computer

Updated Category News Views 211

Investigation Launch: A Call to Action for Shareholders Bragar Eagel & Squire, P.C., a highly regarded law firm focused on shareholder rights, is launching an investigation into potential claims against Super Micro Computer, Inc. (NASDAQ: SMCI). This examination primarily targets the company’s conduct leading up to a class action lawsuit filed against it. The firm is...

Continue Reading
Children’s Place Reports Significant Results and Strategies Ahead

Updated Category News Views 283

Strong Performance in the Fourth Quarter The Children’s Place, Inc. (Nasdaq: PLCE), recognized as North America's leading children's specialty retailer, has reported remarkable progress in its financial performance for the fourth quarter. The company achieved net sales totaling $409 million for this quarter, along with a total of $1.386 billion for the entire fiscal...

Continue Reading
The Incredible Growth of Extra Space Storage Over Time

Updated Category News Views 391

Understanding Extra Space Storage's Historical Returns Extra Space Storage (NYSE: EXR) has significantly outperformed the market during the past 15 years, registering an impressive annualized return of 16.14%. This performance is not just a statistic; it represents a compound growth that can transform an initial investment. The Power of Compound Returns To illustrate...

Continue Reading